Merit Medical Systems is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. The company was founded in 1987 and is based in South Jordan, Utah.
MMSI Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for MMSI, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Merit Medical Systems Inc ranked in the 44th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Merit Medical Systems Inc ended up being:
The company's compound free cash flow growth rate over the past 5.68 years comes in at 0.34%; that's greater than 71.27% of US stocks we're applying DCF forecasting to.
Merit Medical Systems Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -2.08. This coverage rate is greater than that of merely 17.54% of stocks we're observing for the purpose of forecasting via discounted cash flows.
The weighted average cost of capital for the company is 10. This value is greater than 78.43% stocks in the Healthcare sector that generate free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MMSI, try AMGN, IQV, INBP, LNTH, and USPH.
DUBLIN--(BUSINESS WIRE)--The "Global Femoral Closure Devices Market" report has been added to ResearchAndMarkets.com's offering. This report was developed using extensive primary and secondary research by the publisher's analysts. Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of 2019 worldwide market size by product segment, ASPs, sales, and market share f
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Akouos Inc (NASDAQ: AKUS ) Albireo Pharma Inc (NASDAQ: ALB )(announced positive Phase 3 results for odevixibat in a liver disorder called progressive familial intrahepatic cholestasis) Castle Biosciences Inc (NASDAQ: CSTL ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Kura Oncology Inc (NASDAQ: KURA ) Merit Medical Systems, Inc. (NASDAQ: MMSI )(announced sale of manufacturing equipment and associated assets used in its hypotube manufacturing business) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 8) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AEterna Zentaris Inc. (NASDAQ: AEZS )(announced the presentation of data from pediatric study of macimorelin for childhood-o...
A federal appeals court on Thursday upheld sanctions imposed on a father-and-son duo that unsuccessfully brought patent infringement claims against 300 defendants in the medical field, including device-maker Merit Medical Systems Inc, hospitals and individual physicians.